During the past decade, Fakultni Thomayerova Nemocnice; Onkologicke Oddeleni conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni Thomayerova Nemocnice; Onkologicke Oddeleni" #1 collaborator was "Solasia Pharma K.K." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fakultni Thomayerova Nemocnice; Onkologicke Oddeleni" are "Breast Cancer" (2 trials), "Chemotherapy-induced Peripheral Neuropathy" (2 trials), "Colorectal Cancer" (2 trials), "Basal Cell Carcinoma" (1 trials) and "Carcinoma, Hepatocellular" (1 trials). Many other conditions were trialed in "Fakultni Thomayerova Nemocnice; Onkologicke Oddeleni" in a lesser frequency.

Most popular intervention types in "Fakultni Thomayerova Nemocnice; Onkologicke Oddeleni" are "Drug" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Placebo" (4 trials), "Calmangafodipir (5 µmol/kg)" (2 trials), "5-Fluorouracil" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fakultni Thomayerova Nemocnice; Onkologicke Oddeleni" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fakultni Thomayerova Nemocnice; Onkologicke Oddeleni". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Fakultni Thomayerova Nemocnice; Onkologicke Oddeleni, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultni Thomayerova Nemocnice; Onkologicke Oddeleni, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".